- TWD338.23bn
- TWD332.98bn
- TWD241.90bn
- 92
- 38
- 64
- 77
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 163,600 | 186,928 | 192,626 | 292,876 | 241,901 |
Cost of Revenue | |||||
Gross Profit | 11,349 | 15,301 | 15,621 | 23,979 | 22,657 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 155,440 | 175,686 | 181,239 | 275,042 | 226,030 |
Operating Profit | 8,160 | 11,242 | 11,387 | 17,834 | 15,871 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 7,758 | 10,887 | 10,996 | 17,897 | 15,444 |
Provision for Income Taxes | |||||
Net Income After Taxes | 6,169 | 8,610 | 8,648 | 14,175 | 12,044 |
Net Income Before Extraordinary Items | |||||
Net Income | 6,169 | 8,610 | 8,648 | 14,175 | 12,044 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 6,169 | 8,610 | 8,648 | 14,175 | 12,044 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 36.2 | 49 | 49.3 | 80.5 | 68.6 |
Dividends per Share |